LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 345 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $596,000 | +57.3% | 4,544 | +82.6% | 0.05% | +68.8% |
| Q1 2021 | $379,000 | -81.4% | 2,488 | -86.1% | 0.03% | -59.5% |
| Q2 2019 | $2,042,000 | -7.1% | 17,892 | +10.4% | 0.08% | -30.1% |
| Q4 2018 | $2,198,000 | +36.1% | 16,200 | +107.7% | 0.11% | +242.4% |
| Q2 2018 | $1,615,000 | -73.8% | 7,800 | -79.1% | 0.03% | -69.2% |
| Q1 2018 | $6,160,000 | +118.4% | 37,300 | +81.1% | 0.11% | +154.8% |
| Q4 2017 | $2,820,000 | -19.7% | 20,600 | -20.2% | 0.04% | +5.0% |
| Q3 2017 | $3,512,000 | -36.0% | 25,800 | -42.9% | 0.04% | -51.8% |
| Q2 2017 | $5,487,000 | +144.7% | 45,200 | +140.4% | 0.08% | -21.0% |
| Q2 2016 | $2,242,000 | +37.8% | 18,800 | +23.7% | 0.10% | +32.9% |
| Q1 2016 | $1,627,000 | +257.6% | 15,200 | +261.9% | 0.08% | +182.1% |
| Q4 2015 | $455,000 | -63.1% | 4,200 | -70.8% | 0.03% | -69.9% |
| Q3 2015 | $1,233,000 | +166.9% | 14,400 | +140.0% | 0.09% | +111.4% |
| Q1 2015 | $462,000 | – | 6,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |